A Targeting Microbubble for Ultrasound Molecular Imaging

Rationale Microbubbles conjugated with targeting ligands are used as contrast agents for ultrasound molecular imaging. However, they often contain immunogenic (strept)avidin, which impedes application in humans. Although targeting bubbles not employing the biotin-(strept)avidin conjugation chemistry have been explored, only a few reached the stage of ultrasound imaging in vivo, none were reported/evaluated to show all three of the following properties desired for clinical applications: (i) low degree of non-specific bubble retention in more than one non-reticuloendothelial tissue; (ii) effective for real-time imaging; and (iii) effective for acoustic quantification of molecular targets to a high degree of quantification. Furthermore, disclosures of the compositions and methodologies enabling reproduction of the bubbles are often withheld. Objective To develop and evaluate a targeting microbubble based on maleimide-thiol conjugation chemistry for ultrasound molecular imaging. Methods and Results Microbubbles with a previously unreported generic (non-targeting components) composition were grafted with anti-E-selectin F(ab’)2 using maleimide-thiol conjugation, to produce E-selectin targeting microbubbles. The resulting targeting bubbles showed high specificity to E-selectin in vitro and in vivo. Non-specific bubble retention was minimal in at least three non-reticuloendothelial tissues with inflammation (mouse heart, kidneys, cremaster). The bubbles were effective for real-time ultrasound imaging of E-selectin expression in the inflamed mouse heart and kidneys, using a clinical ultrasound scanner. The acoustic signal intensity of the targeted bubbles retained in the heart correlated strongly with the level of E-selectin expression (|r|≥0.8), demonstrating a high degree of non-invasive molecular quantification. Conclusions Targeting microbubbles for ultrasound molecular imaging, based on maleimide-thiol conjugation chemistry and the generic composition described, may possess properties (i)–(iii) desired for clinical applications.

[1]  S. Pochon,et al.  In vivo ultrasound imaging of thrombi using a target-specific contrast agent. , 2002, Academic radiology.

[2]  P. Dayton,et al.  In Vivo Demonstration of Cancer Molecular Imaging with Ultrasound Radiation Force and Buried-Ligand Microbubbles , 2013, Molecular imaging.

[3]  E. C. Beuvery,et al.  Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates. , 1989, Journal of immunological methods.

[4]  Moss Y. Zhao,et al.  Disease-Specific Target Gene Expression Profiling of Molecular Imaging Probes: Database Development and Clinical Validation , 2014, Molecular imaging.

[5]  J. Willmann,et al.  Ultrasound Molecular Imaging Contrast Agent Binding to Both E- and P-Selectin in Different Species , 2012, Investigative radiology.

[6]  Elliot K. Fishman,et al.  Functional Computed Tomography , 1997 .

[7]  K. Vandegriff,et al.  Hemospan: design principles for a new class of oxygen therapeutic. , 2009, Artificial organs.

[8]  O Strohm,et al.  Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.

[9]  F. Kiessling,et al.  The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55) , 2013, European Radiology.

[10]  T. Hamblin,et al.  Response of B-cell lymphoma to a combination of bispecific antibodies and saporin. , 1996, Leukemia research.

[11]  Klaus Ley,et al.  Physiology of Inflammation , 2001, Methods in Physiology Series.

[12]  Jun Wu,et al.  The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function. , 2014, Biomaterials.

[13]  Isabelle Tardy,et al.  BR55: A Lipopeptide-Based VEGFR2-Targeted Ultrasound Contrast Agent for Molecular Imaging of Angiogenesis , 2010, Investigative radiology.

[14]  A. Nunn,et al.  Ultrasound Molecular Imaging of Transient Acute Myocardial Ischemia With a Clinically Translatable P- and E-Selectin Targeted Contrast Agent: Correlation With the Expression of Selectins , 2014, Investigative radiology.

[15]  Y. Liao,et al.  In Vivo Ultrasound Molecular Imaging of Inflammatory Thrombosis in Arteries With Cyclic Arg-Gly-Asp–Modified Microbubbles Targeted to Glycoprotein IIb/IIIa , 2013, Investigative radiology.

[16]  René M. Botnar,et al.  Molecular Imaging With Targeted Contrast Agents , 2009, Topics in magnetic resonance imaging : TMRI.

[17]  K. Ley,et al.  Ultrasound Assessment of Inflammation and Renal Tissue Injury With Microbubbles Targeted to P-Selectin , 2001, Circulation.

[18]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.

[19]  Matthias Nahrendorf,et al.  In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[20]  M. Arditi,et al.  Effects of acoustic radiation force on the binding efficiency of BR55, a VEGFR2-specific ultrasound contrast agent. , 2012, Ultrasound in medicine & biology.

[21]  Eric Allémann,et al.  Molecular Imaging of Human Thrombus With Novel Abciximab Immunobubbles and Ultrasound , 2007, Stroke.

[22]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.

[23]  Fabian Kiessling,et al.  Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38) , 2011, European Radiology.

[24]  F. Kiessling,et al.  Ultrasound Molecular Imaging of E-Selectin in Tumor Vessels Using Poly n-Butyl Cyanoacrylate Microbubbles Covalently Coupled to a Short Targeting Peptide , 2013, Investigative radiology.

[25]  J. Lindner,et al.  Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression. , 2014, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  D. Larkman,et al.  Detection of vascular expression of E-selectin in vivo with MR imaging. , 2006, Radiology.

[27]  K. McIntyre,et al.  Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. , 1994, Immunity.

[28]  S. Cherkaoui,et al.  A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. , 2010, Bioconjugate chemistry.

[29]  S. Muller,et al.  Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes. , 1996, Journal of immunological methods.

[30]  A. Carson,et al.  Ultrasound Detection of Myocardial Ischemic Memory Using an E-Selectin Targeting Peptide Amenable to Human Application , 2014, Molecular imaging.

[31]  R.W.B. Stephens,et al.  IEEE ultrasonics symposium , 1972 .

[32]  T. Bettinger,et al.  Grafting of abciximab to a microbubble-based ultrasound contrast agent for targeting to platelets expressing GP IIb/IIIa - characterization and in vitro testing. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  J. Lindner,et al.  Detection of antecedent myocardial ischemia with multiselectin molecular imaging. , 2012, Journal of the American College of Cardiology.

[34]  F. Jamar,et al.  Scintigraphy using a technetium 99m-labelled anti-E-selectin Fab fragment in rheumatoid arthritis. , 2002, Rheumatology.

[35]  A. Cox,et al.  Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica , 2011, Glycoconjugate Journal.

[36]  E. Rosenthal,et al.  Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma. , 2012, Archives of otolaryngology--head & neck surgery.

[37]  Yulin Liao,et al.  Ultrasound molecular imaging of arterial thrombi with novel microbubbles modified by cyclic RGD in vitro and in vivo , 2011, Thrombosis and Haemostasis.

[38]  S. Kaul,et al.  Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. , 2002, Journal of the American College of Cardiology.

[39]  P. Tipping,et al.  J Am Soc Nephrol 14: 1785–1793, 2003 Intrinsic Renal Cells Are the Major Source of Tumor Necrosis Factor Contributing to Renal Injury in Murine Crescentic , 2022 .

[40]  J. Willmann,et al.  Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. , 2013, Radiology.

[41]  P. Nihoyannopoulos,et al.  Molecular Imaging of Inflammation Using Echocardiography. Advances with the Use of Microbubbles , 2015 .

[42]  Joseph V. Hajnal,et al.  Evaluation of Methods for Sizing and Counting of Ultrasound Contrast Agents , 2012, Ultrasound in medicine & biology.

[43]  A. Klibanov,et al.  Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. , 2012, JACC. Cardiovascular imaging.

[44]  K. Ley,et al.  scVEGF Microbubble Ultrasound Contrast Agents: A Novel Probe for Ultrasound Molecular Imaging of Tumor Angiogenesis , 2010, Investigative radiology.

[45]  Molly L Flexman,et al.  Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. , 2012, Ultrasound in medicine & biology.

[46]  N. Green,et al.  The accessibility of protein-bound dinitrophenyl groups to univalent fragments of anti-dinitrophenyl antibody. , 1976, The Biochemical journal.

[47]  G. Kansas.  Selectins and Their Ligands in Inflammation , 2001 .

[48]  Sunil Unnikrishnan,et al.  Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. , 2012, AJR. American journal of roentgenology.

[49]  J. Turánek,et al.  Preparation of metallochelating microbubbles and study on their site-specific interaction with rGFP-HisTag as a model protein. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[50]  J. Hossack,et al.  11A-4 Molecular Imaging with Targeted Contrast Agents and High Frequency Ultrasound , 2007, 2007 IEEE Ultrasonics Symposium Proceedings.

[51]  Katherine W Ferrara,et al.  Insonation of Targeted Microbubbles Produces Regions of Reduced Blood Flow Within Tumor Vasculature , 2012, Investigative radiology.

[52]  A Haase,et al.  Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. , 2000, Radiology.

[53]  M. Labow,et al.  Heterogeneity of expression of E- and P-selectins in vivo. , 1996, Circulation research.